Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 5, 2012, Pages 717-725

  Maini, Brijeshwar ^a   Naidu, Srihari S ^b   Mulukutla, Suresh ^c   Kleiman, Neal ^d   Schreiber, Theodore ^e   Wohns, David ^f   Dixon, Simon ^g   Rihal, Charanjit ^h   Dave, Rajesh ^a   O'Neill, William ⁱ  

^a Pinnacle Health System   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e HARPER UNIVERSITY HOSPITAL   (United States)

^f SPECTRUM HEALTH   (United States)

^g William Beaumont University Hospital   (United States)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF MIAMI   (United States)

Author keywords

circulatory support; high risk percutaneous coronary intervention; impella 2.5; percutaneous left ventricular assist device

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DEVICE SAFETY; DIASTOLIC BLOOD PRESSURE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART WORK; HIGH RISK PATIENT; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGISTRIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84867896135     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23403     Document Type: Article

References (28)

1. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F,. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
2. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW,. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008; 118: 1146-1154.
3. Serruys PW, Daemen J, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins KD, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll HP,; for the ARTS II Investigators. Three-year follow-up of the ARTS II-Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2008; 3: 450-459.
4. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ,. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
5. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW,; for the SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
6. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM, Morici N, Michev I, Iakovou I, Biondi-Zoccai G, Colombo A,. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 2006; 152: 565-572.
7. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R,. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98: 608-612.
8. Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ,. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97: 990-992.
9. Burzotta F, Paloscia L, Trani C, Mascellanti M, Mongiardo R, Materazzo G, Niccoli G, Di Marco M, Leone AM, Porto I, Mazzari MA, Rebuzzi AG, Schiavoni G, Crea F,. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: A pilot two-centre study. J Cardiovasc Med 2008; 9: 1004-1010.
10. Dixon SR, Henriques JPS, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW,. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial).Initial U.S. experience. JACC Cardiovasc Interv 2009; 2: 91-96.
11. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrøm T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engström AE, Henriques JP,. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device. The Europella Registry. J Am Coll Cardiol 2009; 54: 2430-2434.
12. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW,. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65: 263-267.
13. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Jr,. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007; 70: 532-537.
14. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BA, Tijssen JG, Piek JJ, Baan J Jr,. Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010; 75: 187-194.
15. Sianos G, Morel, MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW,. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
16. Shroyer AL, Cooms LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH,; for the Society of Thoracic Surgeons. The society of thoracic surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75: 1856-1864.
17. Syed AI, Karkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R,. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study? Cardiovasc Revasc Med 2010; 11: 91-97.
18. Schreiber TL, Kodali UR, O'Neill WW, Gangadharan V, Puchrowicz-Ochocki SB, Grines CL,. Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA). Cathet Cardiovasc Diagn 1998; 45: 115-119.
19. Catena E, Milazzo F, Merli M, Paino R, Garatti A, Colombo T, Vitali E,. Echocardiographic evaluation of patients receiving a new left ventricular assist device: The Impella recover 100. Eur J Echocardiogr 2004; 5: 430-437.
20. Wallace TW, Berger JS, Wang A, Velazquez EJ, Brown DL,. Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol 2009; 103: 355-360.
21. Vogel RA, Shawl F, Tommaso C, O'Neill W, Overlie P, O'Toole J, Vandormael M, Topol E, Tabari KK, Vogel J,. Initial report of the national registry of elective cardiopulmonary bypass supported coronary angioplasty. J Am Coll Cardiol 1990; 1: 23-29.
22. Bonow RO,. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 1995; 75: 17A-25A
23. Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia MF, White J,. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheter Cardiovasc Interv 2007: 70: 26-33.
24. Kirschbaum SW, Springeling T, Boersma E, Moelker A, van der Giessen WJ, Serruys PW, de Feyter PJ, van Geuns RJ,. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: Pre- and post-procedural evaluation by cardiac magnetic resonance imaging. JACC Cardiovasc Interv 2010; 3: 392-400.
25. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO,. 2007 focused update of the ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2008; 117: 261-295.
26. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S,; for the BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention. A randomized controlled trial. JAMA 2010; 304: 867-874
27. Health research international 2009 report: US opportunities in acute cardiac assist technologies. Report #0514-1-US-1209-204- December 2009.
28. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G,. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276-1283.